GO:0003677 DNA binding: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0003677 DNA binding describes any molecular function by which a gene product interacts selectively and non-covalently with DNA.
• DNA binding is a molecular_function in the Gene Ontology and includes sequence-specific, structure-specific, and non-specific DNA interactions.
• Many DNA-binding proteins also recognize RNA, revealing broader nucleic-acid binding capabilities.
• DNA binding underlies transcription, replication, repair, recombination, and chromatin organization.
• Dysregulated DNA binding is linked to cancer, developmental disorders, and other diseases.
• CRISPR knockout, point mutation, knock-in, and overexpression models enable functional dissection of DNA-binding proteins.
Description
DNA binding (GO:0003677) is a fundamental molecular function that enables proteins to interact selectively and non-covalently with DNA. This activity is essential for nearly every aspect of genome biology, including transcription, DNA replication, repair, recombination, and chromatin remodeling. Researchers study DNA binding to understand how gene expression is controlled, how mutations contribute to disease, and how drugs can be designed to target DNA-protein interfaces. The Gene Ontology defines DNA binding as any molecular function by which a gene product interacts selectively and non-covalently with DNA. This broad definition encompasses sequence-specific transcription factors, structure-specific recognition proteins, and non-specific DNA-binding proteins such as histones and polymerases. Because DNA binding is central to so many cellular processes, it is a major focus in cancer research, developmental biology, and drug discovery. Experimental approaches such as electrophoretic mobility shift assays, isothermal titration calorimetry, and CRISPR-based genome editing are commonly used to characterize DNA-binding proteins.
DNA binding At A Glance
| GO ID | GO:0003677 |
|---|---|
| GO term | DNA binding |
| Ontology | molecular_function |
| Synonym | microtubule/chromatin interaction; plasmid binding; structure specific DNA binding; structure-specific DNA binding |
| Major function | Selective, non-covalent interaction with DNA |
| Related processes | Transcription, replication, repair, recombination, chromatin organization |
| Example proteins | Msh2-Msh6, Mlh1-Pms1, FOXP3, glucocorticoid receptor, thymine DNA glycosylase |
| Experimental methods | EMSA, ITC, ChIP-seq, CRISPR screens |
What Is GO:0003677?
GO:0003677 DNA binding is defined as any molecular function by which a gene product interacts selectively and non-covalently with DNA (deoxyribonucleic acid). This includes proteins that recognize specific DNA sequences, DNA structures, or DNA modifications, as well as those that bind DNA without sequence specificity. The term is a molecular_function in the Gene Ontology and is distinct from RNA binding, although some proteins exhibit both activities.
Why Is DNA binding Important in Cell Biology?
DNA binding is essential for the regulation of gene expression and the maintenance of genome integrity. Proteins that bind DNA control when and where genes are transcribed, how DNA damage is repaired, and how chromosomes are segregated during cell division. Dysregulation of DNA binding can lead to cancer, developmental disorders, and other diseases, making it a key target for therapeutic intervention.
• DNA binding is required for transcription factor function and gene regulation.
• DNA-binding proteins are involved in DNA mismatch repair and genome stability.
• Structure-specific DNA binding is critical for recognizing damaged or unusual DNA structures.
• Some DNA-binding proteins also bind RNA, expanding their regulatory roles.
• DNA binding is a major mechanism of action for anticancer drugs such as doxorubicin.
• Mutations in DNA-binding domains are associated with developmental disorders and cancer.
• DNA binding is essential for CRISPR-Cas systems and genome editing.
• Understanding DNA binding aids in the design of small-molecule inhibitors.
• DNA binding is a key parameter in drug-DNA interaction studies.
• DNA binding assays are fundamental in molecular biology and drug discovery.
What Happens During DNA binding?
Recognition and Approach
In simple terms: The protein finds and moves toward a specific DNA sequence or structure.
DNA-binding proteins scan the genome for their target sites through a combination of electrostatic interactions and facilitated diffusion. For example, the yeast Msh2-Msh6 heterodimer recognizes mismatched DNA bases with high specificity. The FOXP3 transcription factor binds to specific DNA sequences to regulate gene expression.
Binding and Conformational Change
In simple terms: The protein locks onto DNA and changes shape to form a stable complex.
Upon encountering a target site, the protein undergoes conformational changes that stabilize the protein-DNA complex. The glucocorticoid receptor DNA-binding domain recognizes RNA hairpin structures with high affinity, indicating that some DNA-binding domains can also interact with RNA. Thymine DNA glycosylase is an RNA-binding protein with high selectivity for G-rich sequences, further illustrating dual nucleic-acid binding.
Functional Consequences
In simple terms: Once bound, the protein carries out its biological job, such as activating or repressing genes.
DNA binding can lead to transcriptional activation or repression, DNA repair, or DNA replication. For instance, the Mlh1-Pms1 heterodimer binds DNA to initiate mismatch repair. The forkhead DNA-binding domain binds specific G2-rich RNA sequences, suggesting roles beyond DNA binding.
Regulation and Release
In simple terms: The protein lets go of DNA when its job is done or when signals change.
DNA binding is dynamically regulated by post-translational modifications, cofactors, and changes in cellular conditions. For example, the glucocorticoid receptor DNA-binding domain can be regulated by hormone binding. Drug-DNA interactions, such as those with doxorubicin, can interfere with DNA binding and are exploited in cancer therapy.
Key Genes Involved in GO:0003677 DNA binding
The following genes and proteins are representative examples of DNA-binding molecules with well-documented roles in genome biology and disease.
| Gene | Major Role | Research Relevance |
|---|---|---|
| MSH2 | DNA mismatch repair | Mutations cause Lynch syndrome; studied for DNA binding |
| MSH6 | DNA mismatch repair | Forms heterodimer with MSH2; DNA binding properties |
| MLH1 | DNA mismatch repair | Forms heterodimer with PMS1; DNA binding |
| PMS1 | DNA mismatch repair | Heterodimerizes with MLH1; DNA binding |
| FOXP3 | Transcription factor | Regulatory T cell development; DNA binding |
| NR3C1 | Glucocorticoid receptor | Hormone response; DNA and RNA binding |
| TDG | Thymine DNA glycosylase | Base excision repair; RNA binding |
| FOX | Forkhead box proteins | Transcription regulation; RNA binding |
| TP53 | Tumor suppressor | Sequence-specific DNA binding; cancer |
| MYC | Transcription factor | Cell proliferation; DNA binding |
| NFKB1 | Transcription factor | Immune response; DNA binding |
| SP1 | Transcription factor | GC-box binding; gene regulation |
| CTCF | Chromatin organizer | Insulator function; DNA binding |
| POLR2A | RNA polymerase II | Transcription; DNA binding |
| HIST1H1A | Linker histone | Chromatin structure; DNA binding |
| PARP1 | DNA repair enzyme | Poly(ADP-ribosyl)ation; DNA binding |
| BRCA1 | DNA repair | Homologous recombination; DNA binding |
How Is DNA binding Regulated?
DNA binding is regulated at multiple levels, including post-translational modifications, cofactor interactions, and changes in cellular conditions. For example, the glucocorticoid receptor DNA-binding domain is regulated by hormone binding, which induces conformational changes that affect DNA binding affinity. Thymine DNA glycosylase is an RNA-binding protein with high selectivity for G-rich sequences, and its DNA binding may be modulated by RNA interactions. The forkhead DNA-binding domain binds specific G2-rich RNA sequences, suggesting that RNA can compete with or modulate DNA binding. Additionally, drug-DNA interactions, such as those with doxorubicin, can inhibit DNA binding by intercalating into DNA.
DNA binding and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| MSH2 | Lynch syndrome, colorectal cancer | Knockout cell line, point mutation |
| MLH1 | Lynch syndrome, colorectal cancer | Knockout cell line, knock-in |
| FOXP3 | IPEX syndrome, autoimmune disease | Point mutation, overexpression |
| NR3C1 | Glucocorticoid resistance | Knock-in, knockout |
| TDG | Neurological disorders, cancer | Knockout, overexpression |
Cancer
Dysregulated DNA binding is a hallmark of many cancers. Mutations in DNA mismatch repair genes such as MSH2 and MLH1 impair DNA binding and lead to microsatellite instability and Lynch syndrome. The tumor suppressor TP53 relies on sequence-specific DNA binding to activate cell cycle arrest and apoptosis; loss of this function is common in cancer. Anticancer drugs like doxorubicin target DNA binding by intercalating into DNA and disrupting protein-DNA interactions.
Developmental Disorders
Mutations in transcription factors that bind DNA can cause developmental disorders. FOXP3 mutations impair DNA binding and lead to immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome. The glucocorticoid receptor DNA-binding domain is essential for hormone response, and mutations can cause glucocorticoid resistance.
Neurological and Metabolic Diseases
DNA-binding proteins are implicated in neurological and metabolic diseases. Thymine DNA glycosylase, an RNA-binding protein with high selectivity for G-rich sequences, is involved in DNA repair and epigenetic regulation, and its dysfunction has been linked to neurological disorders. The forkhead DNA-binding domain binds specific G2-rich RNA sequences, and mutations in forkhead genes are associated with metabolic and developmental diseases.
From DNA binding-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of DNA binding affect gene expression? | CRISPR knockout |
| Does a specific point mutation alter DNA binding affinity? | CRISPR point mutation |
| Can a disease-associated mutation be corrected? | CRISPR knock-in |
| Where does the protein bind in the genome? | Tagged knock-in (ChIP-seq) |
| Does overexpression of a DNA-binding protein drive proliferation? | CRISPR overexpression |
| Which DNA-binding proteins are essential for cell survival? | CRISPR library screening |
How to Study the DNA binding Process
| Method | What It Measures | Typical Application |
|---|---|---|
| EMSA | Protein-DNA complex formation | Confirm DNA binding of transcription factors |
| ITC | Binding affinity and thermodynamics | Characterize drug-DNA interactions |
| ChIP-seq | Genome-wide DNA binding sites | Map transcription factor binding |
| CRISPR screen | Gene essentiality and function | Identify DNA repair genes |
| Surface plasmon resonance | Real-time binding kinetics | Measure DNA binding affinity |
| Fluorescence anisotropy | Binding affinity in solution | Study protein-DNA interactions |
| X-ray crystallography | 3D structure of protein-DNA complex | Understand molecular recognition |
Electrophoretic Mobility Shift Assay (EMSA)
EMSA is a classic method to detect protein-DNA complexes and measure DNA binding affinity. It is used to confirm sequence-specific DNA binding of transcription factors such as FOXP3.
Isothermal Titration Calorimetry (ITC)
ITC measures thermodynamic parameters of DNA binding, including binding affinity and stoichiometry. It has been used to study the binding of thalidomide to calf thymus DNA.
Chromatin Immunoprecipitation Sequencing (ChIP-seq)
ChIP-seq identifies genome-wide DNA binding sites of proteins in living cells. It is widely used to map transcription factor binding and histone modifications.
CRISPR Screens
CRISPR knockout and activation screens can identify genes required for DNA binding-dependent processes such as DNA repair and transcription. These screens are powerful for discovering novel DNA-binding proteins and pathways.
How CRISPR Can Be Used to Study GO:0003677 DNA binding
Knockout
CRISPR knockout is used to delete DNA-binding genes and assess loss-of-function phenotypes. For example, knocking out MSH2 in cell lines impairs DNA mismatch repair and increases mutation rates.
Point Mutation
CRISPR point mutation introduces specific amino acid changes to dissect DNA-binding domain function. This is useful for modeling disease-associated mutations in transcription factors like FOXP3.
Knock-in
CRISPR knock-in can insert tags or reporter sequences to study DNA binding in live cells. Tagged knock-in of transcription factors enables ChIP-seq and imaging studies.
Overexpression
CRISPR overexpression (CRISPRa) activates endogenous genes to study the effects of increased DNA-binding protein levels. This is valuable for investigating oncogenic transcription factors.
How EDITGENE Supports DNA binding Research
Researchers studying DNA binding-related genes often need to determine whether a candidate gene is causally involved in a specific biological process or disease. EDITGENE provides comprehensive CRISPR-based services to accelerate this discovery.
Contact EDITGENE today to design your custom CRISPR model for DNA binding research.
Frequently Asked Questions About DNA binding
What is GO:0003677 DNA binding?
GO:0003677 DNA binding is a Gene Ontology molecular function term defined as any molecular function by which a gene product interacts selectively and non-covalently with DNA.
What genes are involved in DNA binding?
Genes such as MSH2, MSH6, MLH1, PMS1, FOXP3, NR3C1, and TDG encode DNA-binding proteins with diverse roles.
How is DNA binding measured?
Common methods include EMSA, ITC, ChIP-seq, and surface plasmon resonance.
What diseases are associated with DNA binding defects?
DNA binding defects are linked to cancer, developmental disorders, and neurological diseases.
Can CRISPR be used to study DNA binding?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are widely used to study DNA-binding proteins.
What is the difference between DNA binding and RNA binding?
DNA binding involves interaction with DNA, while RNA binding involves interaction with RNA; some proteins can do both.
What are synonyms for DNA binding?
Synonyms include microtubule/chromatin interaction, plasmid binding, structure specific DNA binding, and structure-specific DNA binding.
Why is DNA binding important in cancer?
Mutations in DNA-binding proteins such as TP53 and MSH2 disrupt gene regulation and DNA repair, contributing to cancer.
How does doxorubicin interact with DNA?
Doxorubicin intercalates into DNA and disrupts DNA binding of proteins, which contributes to its antitumor activity.
What services does EDITGENE offer for DNA binding research?
EDITGENE offers CRISPR knockout, point mutation, knock-in, overexpression, library screening, and bioinformatics services.
Conclusion
DNA binding (GO:0003677) is a central molecular function that governs gene expression, genome stability, and cellular responses to signals. Understanding the mechanisms, regulation, and disease relevance of DNA-binding proteins is essential for basic research and therapeutic development. CRISPR-based models and advanced biochemical assays provide powerful tools to dissect DNA binding in health and disease.
References
- 1. Drotschmann K et al.. 2002. DNA binding properties of the yeast Msh2-Msh6 and Mlh1-Pms1 heterodimers.. Biol Chem 383(6):969-75 PMID: 12222686
- 2. Zutterling C et al.. 2023. The forkhead DNA-binding domain binds specific G2-rich RNA sequences.. Nucleic Acids Res 51(22):12367-12380 PMID: 37933840
- 4. McGregor LA et al.. 2023. Thymine DNA glycosylase is an RNA-binding protein with high selectivity for G-rich sequences.. J Biol Chem 299(4):104590 PMID: 36889585
- 5. Li J et al.. 2017. DNA-binding properties of FOXP3 transcription factor.. Acta Biochim Biophys Sin (Shanghai) 49(9):792-799 PMID: 28910978
- 6. Parsonnet NV et al.. 2019. The glucocorticoid receptor DNA-binding domain recognizes RNA hairpin structures with high affinity.. Nucleic Acids Res 47(15):8180-8192 PMID: 31147715
- 7. Yasmeen S et al.. 2022. Binding and thermodynamic study of thalidomide with calf thymus DNA: Spectroscopic and computational approaches.. Int J Biol Macromol 207:644-655 PMID: 35278515
- 8. Agudelo D et al.. 2016. Review on the binding of anticancer drug doxorubicin with DNA and tRNA: Structural models and antitumor activity.. J Photochem Photobiol B 158:274-9 PMID: 26971631
